NCT01030900
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +11 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Clinical trial condition
Diffuse Large B-cell Lymphoma
Explore clinical trials studying Diffuse Large B-cell Lymphoma. Study availability and eligibility vary by location and protocol.
213 public trials
54 recruiting studies
Diffuse Large B-cell Lymphoma trial results
NCT05541328
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Novartis Investigative Site East Hanover, New Jersey, United States
NCT03036904
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +10 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Weill Cornell Medicine New York, United States
- Ohio State University Medical Center Columbus, Ohio, United States
NCT03630159
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Emory University School of Medicine SC CTL019 Atlanta, Georgia, United States
- University of Chicago Medical Center Hematology and Oncology Chicago, Illinois, United States
- University of Kansas Hospital and Medical Center U of Kansas Cancer Center Kansas City, Kansas, United States
- Novartis Investigative Site Vienna, Austria
NCT02471911
- Conditions
- Aberrant Motor Behavior in Dementia, Aggression, Behavior, +14 more
- Locations
-
- Weill Cornell Medical College New York, United States
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +10 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Stanford Cancer Center Stanford, California, United States
- Weill Cornell Medical College New York, United States
- Levine Cancer Institute - Blythe Charlotte, North Carolina, United States
- Conditions
- DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Disease Attributes, +17 more
- Locations
-
- Arizona Clinical Research Center Tucson, Arizona, United States
- Arizona Oncology Associates Tucson, Arizona, United States
- Highlands Oncology Group Bentonville, Arkansas, United States
- Highlands Oncology Group Fayetteville, Arkansas, United States
NCT05113576
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Department of Nuclear Medicine and PET/CT Center, The Second Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Completed
A Trial of Pembrolizumab (MK-3475) in Participants With Blood Cancers (MK-3475-013/KEYNOTE-013)
NCT01953692
- Conditions
- Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +27 more
- Locations
-
Not specified
NCT01122472
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Bendigo Hospital Bendigo, Australia
- Concord Repatriation General Hospital Concord, Australia
- Flinders Medical Centre - Repatriation General Hospital Daw Park, Australia
- St Vincent's Hospital, Melbourne Fitzroy, Australia